Finally, to see whether atovaquone synergised with anti-PD-L1 in other models with a different responsiveness to aPD-L1 treatment than the CT26 model, we carried out tumour growth delay experiments in C57/BL6 mice bearing MC38 (colorectal) and LLC (lung) tumours. Here, CD274 is linked to neoplasm.